[1]
D. Bakhotmah and F. Alotaibi, “Synthesis and pharmacological evaluation of new fluorine substituted pyrimido[1,2-b][1,2,4]triazines and [1,3,5]-triazino-[1,2-b][1,2,4]triazines derived as CDK2 potential inhibitors”, Eur. J. Chem., vol. 11, no. 3, pp. 198–205, Sep. 2020.